QA: ALPINE IMMUNE SCIENCES INC. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2017_ALPINE_IMMUNE_SCIENCES_INC.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'IMMUNE DESIGN CORP.', 'shared_tokens': {'immune'}}]}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001626199')"}

Graph

Absolute values for 0001626199, ALPINE IMMUNE SCIENCES INC.

  xvar xval
0 AssetsCurrent 61,663,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 272,000
4 LiabilitiesCurrent 6,499,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,586,000
9 ResearchAndDevelopmentExpense 23,316,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 439,000
13 remainder_ComprehensiveNetIncome -20,000
  yvar yval
0 Assets 61,935,000
1 Liabilities 6,499,000
2 Expenses 31,902,000
3 Revenues 0
4 StockholdersEquity 55,436,000
5 NetIncome -31,463,000
6 ComprehensiveNetIncome -31,473,000
7 BaseVar 50,397,500
8 EconomicCapitalRatio 1.87

Edgar->Model Mapping

Feature Distribution